Skip to main content
SpringerLink
Log in

Risk of ischaemic events at giant cell arteritis diagnosis according to PET/CT findings

  • Original Article
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

Abstract

Purpose

To analyse the risk of ischaemic events in patients with newly diagnosed giant cell arteritis (GCA) according to PET/CT findings.

Methods

PET/CT was performed during the first 10 days of steroid therapy. Clinical manifestations at diagnosis, and physical examination and PET/CT findings were recorded and compared according to the presence or absence of ischaemic symptoms at disease onset. Analysed territories included the ascending aorta, aortic arch, descending aorta, abdominal aorta, carotid arteries, brachiocephalic trunk, vertebral arteries, subclavian arteries and axillary arteries.

Results

The study group comprised 30 patients with a median age of 80.8 years. Of these patients, 21 (70%) reported ischaemic symptoms at diagnosis, and 13 (43.3%) had permanent visual loss. Of the 30 patients, 77.8% showed large vessel vasculitis (including aortic and vertebral artery involvement) on PET/CT, and 60% had isolated involvement of the vertebral territory. Vertebral arteries were more frequently involved in patients with ischaemic symptoms (OR 5.0, 95% CI 0.99–24.86, p = 0.051). The presence of vertebral artery involvement in the absence of aortic involvement was associated with the presence of ischaemic manifestations (Fisher’s exact test, p = 0.001). The presence of aortitis was found to protect against the development of permanent visual loss (OR 19.0, 95% CI 2.79–127.97, p = 0.001).

Conclusion

Our findings suggest an association between the vascular pattern on PET/CT at the time of GCA diagnosis and the risk of ischaemic events.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Mohammad AJ, Nilsson JA, Jacobsson LT, Merkel PA, Turesson C. Incidence and mortality rates of biopsy-proven giant cell arteritis in southern Sweden. Ann Rheum Dis. 2015;74:993–7.

    Article  CAS  PubMed  Google Scholar 

  2. Chandran AK, Udayakumar PD, Crowson CS, Warrington KJ, Matteson EL. The incidence of giant cell arteritis in Olmsted County Minnesota, over a sixty year period 1950-2009. Scand J Rheumatol. 2015;44:215–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Borchers AT, Gershwin ME. Giant cell arteritis: a review of classification, pathophysiology, geoepidemiology and treatment. Autoimmun Rev. 2012;11:A544–54.

    Article  PubMed  Google Scholar 

  4. Weyand CM, Liao YJ, Goronzy JJ. The immunopathology of giant cell arteritis: diagnostic and therapeutic implications. J Neuroophthalmol. 2012;32(3):259–65.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Muratore F, Boiardi L, Cavazza A, Aldigeri R, Pipitone N, Restuccia G, et al. Correlations between histopathological findings and clinical manifestations in biopsy-proven giant cell arteritis. J Autoimmun. 2016;69:94–101.

    Article  PubMed  Google Scholar 

  6. Gonzalez-Gay MA, Garcia-Porrua C. Systemic vasculitis in adults in northwestern Spain, 1988-1997. Clinical and epidemiologic aspects. Medicine (Baltimore). 1999;78(5):292–308.

    Article  CAS  Google Scholar 

  7. Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990;33:1122–8.

    Article  CAS  PubMed  Google Scholar 

  8. de Boysson H, Lambert M, Liozon E, Boutemy J, Maigné G, Olivier Y, et al. Giant-cell arteritis without cranial manifestations: working diagnosis of a distinct disease pattern. Medicine (Baltimore). 2016;95:e3818.

    Article  Google Scholar 

  9. Pérez López J, Solans Laqué R, Bosch Gil JA, Molina Cateriano C, Huguet Redecilla P, Vilardell Tarrés M. Colour-duplex ultrasonography of the temporal and ophthalmic arteries in the diagnosis and follow-up of giant cell arteritis. Clin Exp Rheumatol. 2009;27:S77–82.

    PubMed  Google Scholar 

  10. Förster S, Tato F, Weiss M, Czihal M, Rominger A, Bartenstein P, et al. Patterns of extracranial involvement in newly diagnosed giant cell arteritis assessed by physical examination, colour coded duplex sonography and FDG-PET. Vasa. 2011;40:219–27.

    Article  PubMed  Google Scholar 

  11. Lee Y, Choi S, Ji J, Song G. Diagnostic accuracy of 18F-FDG PET or PET/CT for large vessel vasculitis: a meta-analysis. Z Rheumatol. 2016;75:924–31.

    Article  CAS  PubMed  Google Scholar 

  12. Dejaco C, Ramiro S, Duftner C, Besson FL, Bley TA, Blockmans D, et al. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice. Ann Rheum Dis. 2018;77:636–43.

    Article  PubMed  Google Scholar 

  13. de Boysson H, Liozon E, Lambert M, Parienti J-J, Artigues N, Gefrray L, et al. 18F-fluorodeoxyglucose positron emission tomography and the risk of subsequent aortic complications in giant-cell arteritis. Medicine (Baltimore). 2016;95:e3851.

    Article  CAS  Google Scholar 

  14. Muratore F, Kermani TA, Crowson CS, Green AB, Salvarani C, Matteson EL, et al. Large-vessel giant cell arteritis: A cohort study. Rheumatology (Oxford). 2015;54:463–70.

    Article  Google Scholar 

  15. Nielsen BD, Gormsen LC, Hansen IT, Keller KK, Therkildsen P, Hauge EM. Three days of high-dose glucocorticoid treatment attenuates large-vessel 18F-FDG uptake in large-vessel giant cell arteritis but with a limited impact on diagnostic accuracy. Eur J Nucl Med Mol Imaging. 2018;45:1119–28.

    Article  CAS  PubMed  Google Scholar 

  16. Clifford AH, Murphy EM, Burrell SC, Bligh MP, MacDougall RF, Heathcote JG, et al. Positron emission tomography/computerized tomography in newly diagnosed patients with giant cell arteritis who are taking glucocorticoids. J Rheumatol. 2017;44:1859–66.

    Article  CAS  PubMed  Google Scholar 

  17. Slart RH. FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC. Eur J Nucl Med Mol Imaging. 2018;45:1250–69.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65(1):1–11.

  19. van der Geest KSM, Sandovici M, van Sleen Y, Sanders J, Bos NA, Abdulahad WH, et al. What is the current evidence for disease subsets in giant cell arteritis? Arthritis Rheum. 2018;70:1366–76.

    Article  Google Scholar 

  20. Prieto-gonzález S, Depetris M, García-martínez A, Espígol-frigolé G, Tavera-bahillo I, Corbera-bellata M, et al. Positron emission tomography assessment of large vessel inflammation in patients with newly diagnosed, biopsy-proven giant cell arteritis: a prospective, case-control study. Ann Rheum Dis. 2014;73:1388–92.

    Article  PubMed  Google Scholar 

  21. Muratore F, Pipitone N, Salvarani C, Schmidt WA. Imaging of vasculitis: state of the art. Best Pract Res Clin Rheumatol. 2016;30:688–706.

    Article  PubMed  Google Scholar 

  22. Hommada M, Mekinian A, Brillet P, Larroche C, Dhôte R, Fain O. Aortitis in giant cell arteritis: diagnosis with FDG PET/CT and agreement with CT angiography. Autoimmun Rev. 2017;16:1131–7.

    Article  PubMed  Google Scholar 

  23. Blockmans D, Coudyzer W, Vanderschueren S, Stroobants S, Loeckx D, Heye S, et al. Relationship between fluorodeoxyglucose uptake in the large vessels and late aortic diameter in giant cell arteritis. Rheumatology. 2008;47(8):1179–84.

    Article  CAS  PubMed  Google Scholar 

  24. Agard C, Barrier JH, Dupas B, Ponge T, Mahr A, Fradet G, et al. Aortic involvement in recent-onset giant cell (temporal) arteritis: a case-control prospective study using helical aortic computed tomodensitometric scan. Arthritis Care Res. 2008;59(5):670–6.

    Article  Google Scholar 

  25. Imfeld S, Rottenburger C, Schegk E, Aschwanden M, Juengling F, Staub D, et al. [18-F] FDG positron emission tomography in patients presenting with suspicion of giant cell arteritis – lessons from a vasculitis clinic. Eur Heart J Cardiovasc Imaging. 2018;19:933–40.

    Article  PubMed  Google Scholar 

  26. Gonzalez-Gay MA, Piñeiro A, Gomez-Gigirey A, Garcia-Porrua C, Pego-Reigosa R, Dierssen-Sotos T, et al. Influence of traditional risk factors of atherosclerosis in the development of severe ischemic complications in giant cell arteritis. Medicine (Baltimore). 2004;83:342–7.

    Article  Google Scholar 

  27. Pego-Reigosa R, Garcia-Porrua C, Pineiro A, Dierssen T, Llorca J, Gonzalez-Gay MA. Predictors of cerebrovascular accidents in giant cell arteritis in a defined population. Clin Exp Rheumatol. 2004;22(6 Suppl 36):S13–7.

    CAS  PubMed  Google Scholar 

  28. Salvarani C, Della Bella C, Cimino L, Macchioni P, Formisano D, Bajocchi G, et al. Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis. Rheumatology. 2009;48:250–3.

    Article  CAS  PubMed  Google Scholar 

  29. Liozon E, Dalmay F, Lalloue F, Gondran G, Bezanahary H, Fauchais AL, et al. Risk factors for permanent visual loss in biopsy-proven giant cell arteritis: A study of 339 patients. J Rheumatol. 2016;43(7):1393–9.

    Article  PubMed  Google Scholar 

  30. Schmidt WA, Krause A, Schicke B, Kuchenbecker J, Gromnica-Ihle E. Do temporal artery duplex ultrasound findings correlate with ophthalmic complications in giant cell arteritis? Rheumatology. 2009;48:383–5.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Autoimmune Systemic Diseases Unit, Internal Medicine Department, Hospital Vall d’Hebron, Passeig de la Vall d’Hebron, 119-129, 08035, Barcelona, Spain

    Jaume Mestre-Torres, Fernando Martínez-Valle, Jose Loureiro-Amigo & Roser Solans-Laque

  2. Department of Medicine, Faculty of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain

    Jaume Mestre-Torres, Fernando Martínez-Valle & Roser Solans-Laque

  3. Nuclear Medicine Department, Hospital Vall d’Hebron, Passeig de la Vall d’Hebron, 119-129, 08035, Barcelona, Spain

    Marc Simó-Perdigó & Ignacio Navales

Authors
  1. Jaume Mestre-Torres
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marc Simó-Perdigó
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fernando Martínez-Valle
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ignacio Navales
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jose Loureiro-Amigo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Roser Solans-Laque
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Roser Solans-Laque.

Ethics declarations

Conflicts of interest

None.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the principles of the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. The protocol was approved by the Ethics Committee of the Hospital Vall d’Hebron.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Infection and Inflammation.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mestre-Torres, J., Simó-Perdigó, M., Martínez-Valle, F. et al. Risk of ischaemic events at giant cell arteritis diagnosis according to PET/CT findings. Eur J Nucl Med Mol Imaging 46, 1626–1632 (2019). https://doi.org/10.1007/s00259-019-04339-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-019-04339-y

Keywords

Search

Navigation